Successful rapid desensitization to the antibody–drug conjugate brentuximab vedotin in a patient with refractory Hodgkin lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Successful rapid desensitization to the antibody–drug conjugate brentuximab vedotin in a patient with refractory Hodgkin lymphoma

Published:2015-01-12 Issue:1 Volume:22 Page:188-192
ISSN:1078-1552
Container-title:Journal of Oncology Pharmacy Practice
language:en
Short-container-title:J Oncol Pharm Pract

Author:

Fizesan Marie¹²,Boin Christopher¹²,Aujoulat Olivier¹²,Newinger Georges²³,Ghergus Dana²⁴,Watier Hervé⁵,Lustig Hélène¹²,Ojeda-Uribe Mario²⁴

Affiliation:

1. Pharmacie Centrale, Mulhouse, France

2. Hôpital E Muller, Mulhouse, France

3. Service de Pneumologie et Allergologie, Mulhouse, France

4. Service d’Hématologie Clinique et Unité de Thérapie Cellulaire, Mulhouse, France

5. CNRS UMR 7292, Université François-Rabelais, CHRU de Tours, Tours, France

Publisher

SAGE Publications

Subject

Pharmacology (medical),Oncology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1078155214567164

Reference10 articles.

1. Lysosomal Trafficking and Cysteine Protease Metabolism Confer Target-specific Cytotoxicity by Peptide-linked Anti-CD30-Auristatin Conjugates

2. cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugate with potent and selective antitumor activity

3. The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma

4. Adverse events to monoclonal antibodies used for cancer therapy: Focus on hypersensitivity responses

5. Severe infusion reactions to brentuximab vedotin in two patients with Hodgkin lymphoma previously treated with allogeneic stem cell transplantation

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Desensitization to Brentuximab Vedotin after anaphylaxis in refractory Hodgkin's lymphoma;Journal of Oncology Pharmacy Practice;2022-01-21

2. Hypersensitivity Reactions to Cancer Chemotherapy: Practical Recommendations of ARADyAL for Diagnosis and Desensitization;Journal of Investigational Allergy and Clinical Immunology;2021-10-22

3. Rapid desensitization for brentuximab vedotin (Adceteris®) allergy: a case report;Clinical and Molecular Allergy;2018-10-29

4. Brentuximab Vedotin: A Nursing Perspective on Best Practices and Management of Associated Adverse Events;Clinical Journal of Oncology Nursing;2018-08-01

5. Desensitization of Brentuximab Vedotin in a Patient with Hodgkin Lymphoma;Cureus;2018-07-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3